deferoxamine and citric acid, iron, sorbitol drug combination

deferoxamine has been researched along with citric acid, iron, sorbitol drug combination in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dekker, AW; Keunen, JE; Marx, JJ; Neijt, JP; Nortier, JW; Ros, FE; van Asbeck, BS; Voest, EE	1
Ganguly, NK; Gupta, R; Gupta, S; Joshi, K	1

Trials

1 trial(s) available for deferoxamine and citric acid, iron, sorbitol drug combination

Article	Year
Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity. Cancer chemotherapy and pharmacology, 1993, Volume: 31, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Citrates; Citric Acid; Deferoxamine; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Drug Synergism; Eye; Female; Ferric Compounds; Humans; Iron; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Sorbitol; Tumor Cells, Cultured	1993

Article

Year

Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity.

Cancer chemotherapy and pharmacology, 1993, Volume: 31, Issue:5

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Citrates; Citric Acid; Deferoxamine; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Drug Synergism; Eye; Female; Ferric Compounds; Humans; Iron; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Sorbitol; Tumor Cells, Cultured

1993

Other Studies

1 other study(ies) available for deferoxamine and citric acid, iron, sorbitol drug combination

Article	Year
Role of iron and iron chelation therapy in oxygen free radical mediated tissue injury in an ascending mouse model of chronic pyelonephritis. Comparative immunology, microbiology and infectious diseases, 1997, Volume: 20, Issue:4 Topics: Animals; Chelation Therapy; Chronic Disease; Citric Acid; Deferoxamine; Disease Models, Animal; Drug Combinations; Escherichia coli; Escherichia coli Infections; Female; Ferric Compounds; Free Radicals; Glucosephosphate Dehydrogenase; Glutathione Reductase; Histocytochemistry; Iron; Kidney; L-Lactate Dehydrogenase; Lipid Peroxides; Luminescent Measurements; Mice; Mice, Inbred BALB C; Pyelonephritis; Reactive Oxygen Species; Sorbitol	1997

Article

Year

Role of iron and iron chelation therapy in oxygen free radical mediated tissue injury in an ascending mouse model of chronic pyelonephritis.

Comparative immunology, microbiology and infectious diseases, 1997, Volume: 20, Issue:4

Topics: Animals; Chelation Therapy; Chronic Disease; Citric Acid; Deferoxamine; Disease Models, Animal; Drug Combinations; Escherichia coli; Escherichia coli Infections; Female; Ferric Compounds; Free Radicals; Glucosephosphate Dehydrogenase; Glutathione Reductase; Histocytochemistry; Iron; Kidney; L-Lactate Dehydrogenase; Lipid Peroxides; Luminescent Measurements; Mice; Mice, Inbred BALB C; Pyelonephritis; Reactive Oxygen Species; Sorbitol

1997